The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.
Leach, Martin O Brindle, K Evelhoch, J Griffiths, John R Horsman, Michael R Jackson, A Jayson, Gordon C Judson, Ian R Knopp, M Maxwell, Ross J
Leach, Martin O
Brindle, K
Evelhoch, J
Griffiths, John R
Horsman, Michael R
Jackson, A
Jayson, Gordon C
Judson, Ian R
Knopp, M
Maxwell, Ross J
Citations
Altmetric:
Abstract
Vascular and angiogenic processes provide an important target for novel cancer therapeutics. Dynamic contrast-enhanced magnetic resonance imaging is being used increasingly to noninvasively monitor the action of these therapeutics in early-stage clinical trials. This publication reports the outcome of a workshop that considered the methodology and design of magnetic resonance studies, recommending how this new tool might best be used.
Description
Date
2005-05-09
Publisher
Collections
Keywords
Cancer
Type
Article
Citation
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. 2005, 92 (9):1599-610 Br. J. Cancer